27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs) have an endless self-renewal capacity and can theoretically differentiate into all types of lineages. They thus represent an unlimited source of cells for therapies of regenerative diseases, such as Duchenne muscular dystrophy (DMD), and for tissue repair in specific medical fields. However, at the moment, the low number of efficient specific lineage differentiation protocols compromises their use in regenerative medicine. We developed a two-step procedure to differentiate hESCs and dystrophic hiPSCs in myogenic cells. The first step was a culture in a myogenic medium and the second step an infection with an adenovirus expressing the myogenic master gene MyoD. Following infection, the cells expressed several myogenic markers and formed abundant multinucleated myotubes in vitro. When transplanted in the muscle of Rag/ mdx mice, these cells participated in muscle regeneration by fusing very well with existing muscle fibers. Our findings provide an effective method that will permit to use hESCs or hiPSCs for preclinical studies in muscle repair.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          MyoD and the transcriptional control of myogenesis.

          The basic helix-loop-helix myogenic regulatory factors MyoD, Myf5, myogenin and MRF4 have critical roles in skeletal muscle development. Together with the Mef2 proteins and E proteins, these transcription factors are responsible for coordinating muscle-specific gene expression in the developing embryo. This review highlights recent studies regarding the molecular mechanisms by which the muscle-specific myogenic bHLH proteins interact with other regulatory factors to coordinate gene expression in a controlled and ordered manner.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Feeder-independent culture of human embryonic stem cells.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.

              An important corollary to the recent advances in our understanding of the primary cause of Duchenne muscular dystrophy, is the validation of genuine genetic homologues as animal models of the disease in which potential therapies can be tested. The persistent skeletal muscle necrosis that characterizes human Duchenne muscular dystrophy is also seen in the mdx mouse and is, in both, a consequence of a deficiency of dystrophin, probably within the muscle fibres themselves. As injected muscle precursor cells of one genotype can fuse with host muscle fibres of a different genotype and express the donor genes, we decided to test grafts of normal muscle precursor cells to see if they could induce synthesis of dystrophin in innately dystrophin-deficient mdx muscle fibres. We show that injected normal muscle precursor cells can fuse with pre-existing or regenerating mdx muscle fibres to render many of these fibres dystrophin-positive and so to partially or wholly rescue them from their biochemical defect.
                Bookmark

                Author and article information

                Journal
                Mol Ther
                Mol. Ther
                Molecular Therapy
                Nature Publishing Group
                1525-0016
                1525-0024
                November 2012
                18 September 2012
                1 November 2012
                : 20
                : 11
                : 2153-2167
                Affiliations
                [1 ]Unité de recherche de recherche en Génétique Humaine, Centre de recherche de CHUL, CHUQ, Faculté de médecine, Université Laval , Québec, Québec, Canada
                [2 ]Laboratory of Clinical Pharmacology and Therapeutics, Department of Pharmaceutical Sciences, Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Sojo University , Kumamoto, Japan
                [3 ]Centre de Recherche du Centre Hospitalier Universitaire de Québec (CHUQ), The APOGEE-Net/CanGeneTest Research and Knowledge Network in Genetic Health Services and Policy, Service de Génétique Médicale, Département de Pédiatrie, Faculté de Médecine, Université Laval , Québec, Québec, Canada
                [4 ]Centre de Recherche du Centre Hospitalier Universitaire de Québec (CHUQ), The APOGEE-Net/CanGeneTest Research and Knowledge Network in Genetic Health Services and Policy, Service de Génétique Médicale, Département de biologie médicale, Faculté de Médecine, Université Laval , Québec, Québec, Canada
                Author notes
                [* ]Unité de recherche en Génétique Humaine, Centre de recherche du CHUL, 2705, boulevard Laurier, Québec, Québec G1V 4G2, Canada. E-mail: Jacques-P.Tremblay@ 123456crchul.ulaval.ca
                Article
                mt2012188
                10.1038/mt.2012.188
                3498803
                22990676
                c4376e74-afd7-4ad0-9191-10cf3d04b79d
                Copyright © 2012 The American Society of Gene & Cell Therapy

                This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/

                History
                : 04 November 2011
                : 19 May 2012
                Categories
                Original Article

                Molecular medicine
                Molecular medicine

                Comments

                Comment on this article